These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. B-type natriuretic Peptide assay for the diagnosis and prognosis of patent ductus arteriosus in preterm infants. Kim JS; Shim EJ Korean Circ J; 2012 Mar; 42(3):192-6. PubMed ID: 22493614 [TBL] [Abstract][Full Text] [Related]
12. [Clinical characteristics and cardiac hemodynamic changes of patent ductus ateriosus in preterm infants]. Lu D; Liu Y; Tong X Zhonghua Er Ke Za Zhi; 2015 Mar; 53(3):187-93. PubMed ID: 26165015 [TBL] [Abstract][Full Text] [Related]
13. N-terminal probrain natriuretic peptide and patent ductus arteriosus in preterm infants. Nuntnarumit P; Khositseth A; Thanomsingh P J Perinatol; 2009 Feb; 29(2):137-42. PubMed ID: 19020527 [TBL] [Abstract][Full Text] [Related]
17. Patent ductus arteriosus in preterm infants born at 23-24 weeks' gestation: Should we pay more attention? Dani C; Mosca F; Cresi F; Lago P; Lista G; Laforgia N; Del Vecchio A; Corvaglia L; Paolillo P; Trevisanuto D; Capasso L; Fanos V; Maffei G; Boni L Early Hum Dev; 2019 Aug; 135():16-22. PubMed ID: 31212222 [TBL] [Abstract][Full Text] [Related]
18. Late Acetaminophen Therapy for Patent Ductus Arteriosus in the Preterm Neonate. King R; Colon M; Stanfel L; Tauber KA J Pediatr Pharmacol Ther; 2020; 25(6):507-513. PubMed ID: 32839654 [TBL] [Abstract][Full Text] [Related]